Caleres Inc. Common Stock (CAL)

FairStock Score: 38/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Caleres is a classic Peter Lynch turnaround, not a compounder. The Lynch category computed from the filed annual results is TURNAROUND — loss in the latest year after earlier profits. It sells footwear through Famous Footwear and a brand portfolio, a competitive retail business with no obvious wide moat. At the 2026-10-13 close of $12.30, FairStock shows a market cap of $424.4M, P/E 8.04, P/B 0.60, EV/EBITDA 7.96, and FCF yield 14.8% on trailing free cash flow of $62.9M. The Graham Number is $25.92, suggesting a 52.55% margin of safety, and Piotroski is 7/9. Those are cheap, cash-generative signals. But FY2025 ended 2026-01-31 produced revenue of $2.8B, net loss of $6.7M, and diluted EPS of -$0.21, after FY2024 net income of $107.3M and EPS $3.09, and FY2023 net income of $171.4M and EPS $4.80. Recent quarters show improvement: fiscal Q2 2026 ended 2026-08-01 had revenue $695.5M, net income $58.6M, and diluted EPS $1.71; fiscal Q1 2026 ended 2026-05-02 had net income $14.3M and EPS $0.42. Still, ROCE is only 1.78%, ROE 7.71%, D/E 1.29, and Altman Z-Score 1.00, so balance-sheet risk is real. The FairStock score is 38/100. This is a statistically cheap but fragile turnaround: the price discounts trouble, but the business must prove the annual loss was temporary and improve returns on capital.

In plain English: Caleres sells shoes through Famous Footwear and other brands. It lost money in its latest full year after earning profits before, but recent quarters have been profitable and it generates cash. At $12.30, the shares look cheap compared with the company's assets and earnings, though debt and weak returns make it risky.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-08-01) · fiscal Q1 2026 10-Q (period ended 2026-05-02) · fiscal Q3 2025 10-Q (period ended 2025-11-01) · fiscal Q2 2025 10-Q (period ended 2025-08-02) · FY2025 10-K (period ended 2026-01-31) · FY2024 10-K (period ended 2025-02-01) · FY2023 10-K (period ended 2024-02-03)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer